Literature DB >> 18320146

The conundrum of hyperuricemia, metabolic syndrome, and renal disease.

Takahiko Nakagawa1, Pietro Cirillo, Waichi Sato, Michael Gersch, Yuri Sautin, Carlos Roncal, Wei Mu, L Gabriela Sánchez-Lozada, Richard J Johnson.   

Abstract

The level of serum uric acid in human has been increasing over the last decades, and correlates with an increase prevalence of renal disease and metabolic syndrome. Understanding the role of uric acid in these conditions may provide clues for preventing the current epidemic of renal disease. Controversy still remains if hyperuricemia is simply a consequence or a cause of renal disease although epidemiological studies have attempted to resolve this issue. In this review, we discuss the clinical and experimental evidence for a causal role of hyperuricemia in renal diseases and potential relationships of hyperuricemia with metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18320146      PMCID: PMC2895906          DOI: 10.1007/s11739-008-0141-3

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  49 in total

1.  The kidney in gout.

Authors:  J H TALBOTT; K L TERPLAN
Journal:  Medicine (Baltimore)       Date:  1960-12       Impact factor: 1.889

2.  Gout, familial hypericaemia, and renal disease.

Authors:  H DUNCAN; A S DIXON
Journal:  Q J Med       Date:  1960-01

3.  Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats.

Authors:  Laura G Sánchez-Lozada; Edilia Tapia; José Santamaría; Carmen Avila-Casado; Virgilia Soto; Tomás Nepomuceno; Bernardo Rodríguez-Iturbe; Richard J Johnson; Jaime Herrera-Acosta
Journal:  Kidney Int       Date:  2005-01       Impact factor: 10.612

4.  Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.

Authors:  P J Savage; S L Pressel; J D Curb; E B Schron; W B Applegate; H R Black; J Cohen; B R Davis; P Frost; W Smith; N Gonzalez; G P Guthrie; A Oberman; G Rutan; J L Probstfield; J Stamler
Journal:  Arch Intern Med       Date:  1998-04-13

5.  Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants.

Authors:  M Whiteman; B Halliwell
Journal:  Free Radic Res       Date:  1996-09

6.  Nitrosation of uric acid by peroxynitrite. Formation of a vasoactive nitric oxide donor.

Authors:  K A Skinner; C R White; R Patel; S Tan; S Barnes; M Kirk; V Darley-Usmar; D A Parks
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

7.  Insulin resistance in patients with chronic kidney disease.

Authors:  Shuzo Kobayashi; Kyoko Maesato; Hidekazu Moriya; Takayasu Ohtake; Toshio Ikeda
Journal:  Am J Kidney Dis       Date:  2005-02       Impact factor: 8.860

8.  Effect of insulin on renal sodium and uric acid handling in essential hypertension.

Authors:  E Muscelli; A Natali; S Bianchi; R Bigazzi; A Q Galvan; A M Sironi; S Frascerra; D Ciociaro; E Ferrannini
Journal:  Am J Hypertens       Date:  1996-08       Impact factor: 2.689

9.  Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study.

Authors:  Bjoern Becker; Florian Kronenberg; Jan T Kielstein; Hermann Haller; Christian Morath; Eberhard Ritz; Danilo Fliser
Journal:  J Am Soc Nephrol       Date:  2005-03-02       Impact factor: 10.121

10.  Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites.

Authors:  Rémon A M H Van Aubel; Pascal H E Smeets; Jeroen J M W van den Heuvel; Frans G M Russel
Journal:  Am J Physiol Renal Physiol       Date:  2004-09-28
View more
  19 in total

1.  The dual effect of uric acid on the burning endothelium: gasoline or water?

Authors:  Roberto Delsignore; Diego Ardigo
Journal:  Intern Emerg Med       Date:  2009-12       Impact factor: 3.397

2.  The relationship between serum levels of uric acid and prognosis of infection in critically ill patients.

Authors:  He-Chen Zhu; Ruo-Lan Cao
Journal:  World J Emerg Med       Date:  2012

Review 3.  Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage?

Authors:  Davide Stellato; Luigi Francesco Morrone; Chiara Di Giorgio; Loreto Gesualdo
Journal:  Intern Emerg Med       Date:  2011-08-13       Impact factor: 3.397

4.  Hyperuricemia and metabolic syndrome: associations with chronic kidney disease.

Authors:  Lai-Chu See; Chang-Fu Kuo; Fang-Hsiu Chuang; Yu-Ming Shen; Yu-Shien Ko; Yu-Ming Chen; Kuang-Hui Yu
Journal:  Clin Rheumatol       Date:  2010-04-22       Impact factor: 2.980

5.  Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome.

Authors:  J P Gonçalves; A Oliveira; M Severo; A C Santos; C Lopes
Journal:  Endocrine       Date:  2012-02-21       Impact factor: 3.633

6.  Relationship between serum uric Acid and bone mineral density in the general population and in rats with experimental hyperuricemia.

Authors:  Dihua Zhang; I Alexandru Bobulescu; Naim M Maalouf; Beverley Adams-Huet; John Poindexter; Sun Park; Fuxin Wei; Christopher Chen; Orson W Moe; Khashayar Sakhaee
Journal:  J Bone Miner Res       Date:  2015-06       Impact factor: 6.741

7.  Hyperuricaemia and the metabolic syndrome in type 2 DM.

Authors:  Anthonia O Ogbera; Alfred O Azenabor
Journal:  Diabetol Metab Syndr       Date:  2010-04-20       Impact factor: 3.320

8.  Xanthine oxidase inhibitors in elderly patients with heart failure: useful or useless?

Authors:  Vivianne Presta; Barbara Citoni; Giuliano Tocci
Journal:  Intern Emerg Med       Date:  2019-05-13       Impact factor: 3.397

9.  Salivary uric acid as a noninvasive biomarker of metabolic syndrome.

Authors:  Maria Soukup; Izabela Biesiada; Aaron Henderson; Benmichael Idowu; Derek Rodeback; Lance Ridpath; Edward G Bridges; Andrea M Nazar; Kristie Grove Bridges
Journal:  Diabetol Metab Syndr       Date:  2012-04-19       Impact factor: 3.320

10.  Hyperuricemia: An Early Marker for Severity of Illness in Sepsis.

Authors:  Sana R Akbar; Dustin M Long; Kashif Hussain; Ahmad Alhajhusain; Umair S Ahmed; Hafiz I Iqbal; Ailia W Ali; Rachel Leonard; Cheryl Dalton
Journal:  Int J Nephrol       Date:  2015-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.